FIC
REGN icon

FCG Investment Company’s Regeneron Pharmaceuticals REGN Stock Holding History

FCG Investment Company’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-819
Closed -$583K – 108
2024
Q4 		$583K Sell
819
-205
-20% -$172K 0.35% 60
2024
Q3 		$1.08M Buy
1,024
+211
+26% +$235K 0.71% 48
2024
Q2 		$854K Buy
813
+59
+8% +$57.2K 0.65% 49
2024
Q1 		$726K Buy
754
+31
+4% +$29.5K 0.58% 57
2023
Q4 		$635K Buy
+723
New +$595K 0.62% 47

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCG Investment Company's REGN Position: Q1 2025 in Review

FCG Investment Company sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 819 shares — an estimated $583K sold.

FCG Investment Company first reported a position in REGN in Q4 2023 and held it in 5 quarters. The position peaked at $1.08M in Q3 2024. 1,290 funds tracked by Wall St. Rank hold REGN as of Q1 2025.

  • FCG Investment Company reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • FCG Investment Company sold 819 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $583K.
  • FCG Investment Company first reported a position in Regeneron Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • FCG Investment Company's Regeneron Pharmaceuticals position peaked at $1.08M in Q3 2024.
  • 1,290 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.

Based on FCG Investment Company's 13F filing for Q1 2025, filed 13 May 2025.